Skip to content

Clinical Outcomes Mandible: Buffered 1% vs. Non-Buffered 1% Lidocaine

Pilot Study: Comparison of Buffered 1% vs. Non-Buffered 1% Lidocaine Used in Dental and Oral Surgical Procedures: Clinical Outcomes Mandible

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03127943
Enrollment
24
Registered
2017-04-25
Start date
2017-05-01
Completion date
2018-04-01
Last updated
2019-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Local

Keywords

lidocaine, mandible

Brief summary

Assess the clinical impact of Buffered 1% lidocaine with epinephrine as compared to the Non-buffered 1% lidocaine with epinephrine in dental and oral surgical procedures.

Detailed description

Background: Based on the discovery of its topical and locally injected anesthetic effects at the end of the 19th century, cocaine was rapidly adopted as a means of blocking painful sensory impulses from the periphery during surgical procedures.(1) In the last decade local anesthetics have been administered more often, alone or in combination with IV or inhalation anesthetics for most surgical procedures. For clinical procedures in the head and neck the local anesthetic drugs have been combined with a vasoconstrictor, usually epinephrine, to prolong the anesthetic effect at the locally injected anatomic site. To achieve pulpal and periosteal anesthesia by nerve or field block for procedures in dentistry, lidocaine at a 2% concentration has been preferred by clinicians for its reliable outcomes. To prolong the shelf life of the vasopressor, the drug combination must be formulated with a low pH, approximately pH 3.5 for lidocaine with 1/100k epinephrine (Epi). With a better understanding of the pharmacology, new options for improving local anesthetic effectiveness including buffering the commercially supplied drugs to a neutral pH just prior to injection, continue to emerge.(2) When injected, the low pH causes the sting felt by patients on injection. Buffering to a neutral pH eliminates this discomfort and makes the maximum concentration of the non-ionized form of the anesthetic drug immediately available to the targeted nerve membrane.(3-7) Until recently, buffering local anesthetics containing Epi followed with bicarbonate just prior to injection was impractical for the quantities used in intraoral procedures. However, today we do have options to efficiently accomplish this buffering technique.(Anutra Medical, Research TrianglePark, NC). Buffering local anesthetics just prior to use produces positive outcomes including less sting on injection, faster onset of the drug, and possibly added drug potency, ie the same positive clinical effect at lower dosage. In pilot studies with healthy adults as their own controls investigators have shown that Buffered 1% lidocaine with 1/100k Epi was as effective as Non-buffered 2% lidocaine with 1/100k Epi for pulpal anesthesia on a 1st molar or canine after nerve block in the mandible or field block in the maxilla-Phase one of this study.(8,9) These outcomes could be beneficial for performing multiple procedures in children whose lidocaine dosage is limited by body weight or others with chronic liver disease. Rationale: The recently reported results from the two clinical studies involving buffered lidocaine with Epi have led to clinicians questioning whether the Buffered 1% lidocaine with Epi might be as effective for achieving pulpal and periosteal anesthesia for dental procedures as Non-Buffered 1% lidocaine with Epi-Phase two of this study, outcomes not usually considered by most clinicians. This protocol addresses that question. Specific Aims: Compare clinical depths of pulpal anesthesia for maxillary(Phase one) and mandibular(Phase two) molar and canine teeth at 30min intervals Post-injection of lidocaine Assess pain levels during injection Assess time after injection to lower lip numb Hypotheses: No differences exist in anesthetic depth for pulpal anesthesia after intraoral injection mandibular nerve block between Buffered 1% lidocaine with 1/100k epinephrine as compared to Non-buffered 1% lidocaine with 1/100k epinephrine. Subjects will serve as their own controls in a cross-over AB/BA study design which is uniform within sequences, uniform within periods, and balanced

Interventions

DRUGLidocaine

Efficacy for mandibular molar and canine anesthesia

Sponsors

University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Masking description

double blind

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

Age 18-30 years American Society Anesthesiologists I,II

Exclusion criteria

Allergy to lidocaine class of anesthetic drugs Local anesthetic drug use in past week Current symptoms in teeth or oral mucosa

Design outcomes

Primary

MeasureTime frameDescription
Mean Time to Pulpal Response After Mandibular Molar AnesthesiaEvery 30 minutes up to 120 minutes TotalSubjects' mandibular molar teeth will be tested before anesthetic and every 30 minutes with cold and electric pulp test for presence of anesthesia as reported by subjects yes or no
Mean Time to Pulpal Response After Mandibular Canine Anesthesia30 minute intervals up to 120 minutesSubjects' mandibular molar teeth will be tested before anesthetic and every 30 minutes with cold and electric pulp test for presence of anesthesia as reported by subjects yes or no

Countries

United States

Participant flow

Participants by arm

ArmCount
All Study Participants
Participants who were to receive either Buffered 1% lidocaine or Non-Buffered 2% Lidocaine
24
Total24

Baseline characteristics

CharacteristicAll Study Participants
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
24 Participants
Age, Continuous24 years
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
21 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
Region of Enrollment
United States
24 Participants
Sex: Female, Male
Female
13 Participants
Sex: Female, Male
Male
11 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 240 / 24
other
Total, other adverse events
0 / 240 / 24
serious
Total, serious adverse events
0 / 240 / 24

Outcome results

Primary

Mean Time to Pulpal Response After Mandibular Canine Anesthesia

Subjects' mandibular molar teeth will be tested before anesthetic and every 30 minutes with cold and electric pulp test for presence of anesthesia as reported by subjects yes or no

Time frame: 30 minute intervals up to 120 minutes

ArmMeasureValue (MEAN)Dispersion
Buffered 1% Lidocaine, Then Non-Buffered 1% LidocaineMean Time to Pulpal Response After Mandibular Canine Anesthesia81.3 minutesStandard Deviation 44.7
Non-buffered 1% Lididocaine, the Buffered 1% LidocaineMean Time to Pulpal Response After Mandibular Canine Anesthesia97.5 minutesStandard Deviation 43.6
Primary

Mean Time to Pulpal Response After Mandibular Molar Anesthesia

Subjects' mandibular molar teeth will be tested before anesthetic and every 30 minutes with cold and electric pulp test for presence of anesthesia as reported by subjects yes or no

Time frame: Every 30 minutes up to 120 minutes Total

ArmMeasureValue (MEAN)Dispersion
Buffered 1% Lidocaine, Then Non-Buffered 1% LidocaineMean Time to Pulpal Response After Mandibular Molar Anesthesia100 minutesStandard Deviation 37.2
Non-buffered 1% Lididocaine, the Buffered 1% LidocaineMean Time to Pulpal Response After Mandibular Molar Anesthesia106 minutesStandard Deviation 41.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026